Author Topic: (Abst.) Alemtuzumab stabilizes patient who had changed from Tysabri to Zinbryta  (Read 43 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8124
  • MS diagnosed 1980
  • Location: Pacific Northwest

This sounds as if Lemtrada (alemtuzumab) turned out to be useful in an unexpected way. A patient who had changed from Tysabri to Zinbryta (daclizumab) developed severe CNS inflammation, but according to this, treatment with alemtuzumab had the effect of stabilizing the patient's condition. From PubMed, April 10, 2018:

https://www.ncbi.nlm.nih.gov/pubmed/29631243
MS Speaks--online for 12 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
39 Views
Last post October 11, 2017, 07:59:26 am
by agate
0 Replies
56 Views
Last post December 23, 2017, 08:57:09 am
by agate
0 Replies
46 Views
Last post December 28, 2017, 08:42:01 pm
by agate
0 Replies
59 Views
Last post July 23, 2018, 07:49:08 pm
by agate
0 Replies
18 Views
Last post April 10, 2019, 04:24:57 pm
by agate